These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35247437)
1. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC Life Sci; 2022 May; 296():120435. PubMed ID: 35247437 [TBL] [Abstract][Full Text] [Related]
2. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy. Mao J; Meng X; Zhao C; Yang Y; Liu G Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
4. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349 [TBL] [Abstract][Full Text] [Related]
5. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Lakkadwala S; Singh J Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer. Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595 [TBL] [Abstract][Full Text] [Related]
8. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062 [TBL] [Abstract][Full Text] [Related]
9. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic- Banstola A; Duwa R; Emami F; Jeong JH; Yook S Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
12. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival. Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818 [TBL] [Abstract][Full Text] [Related]
13. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Ramalho MJ; Sevin E; Gosselet F; Lima J; Coelho MAN; Loureiro JA; Pereira MC Int J Pharm; 2018 Jul; 545(1-2):84-92. PubMed ID: 29715532 [TBL] [Abstract][Full Text] [Related]
15. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy. Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897 [TBL] [Abstract][Full Text] [Related]
16. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related]
17. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035 [TBL] [Abstract][Full Text] [Related]
18. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors. Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729 [TBL] [Abstract][Full Text] [Related]
19. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
20. Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth. Salzano G; Zappavigna S; Luce A; D'Onofrio N; Balestrieri ML; Grimaldi A; Lusa S; Ingrosso D; Artuso S; Porru M; Leonetti C; Caraglia M; De Rosa G J Biomed Nanotechnol; 2016 Apr; 12(4):811-30. PubMed ID: 27301207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]